comparemela.com

Latest Breaking News On - Proteomics international laboratories - Page 14 : comparemela.com

ScoPo s Powerplays: Volpara leads a minor ASX small cap health sector renaissance

Protein Expression (Prokaryotic, Mammalian Cell) Market Trends/Analysis Report 2022: A Global $6 5 Billion Market by 2030 - Increasing Research in Proteomics and Genomics Bodes Well

Proteomics International Laboratories Limited (ASX:PIQ) Announce AMA Approval of PromarkerD Test for Diabetic Kidney Disease

Proteomics International Laboratories Ltd Company Summary & News ASX:PIQ

Proteomics International Laboratories (ASX:PIQ) is a medical technology company focused on proteomics – the industrial scale study of the structure and function of proteins. In the last few years, proteins have become the drug class of choice for the pharmaceutical industry because of their intimate role in biological systems. Proteomics technology is now playing a key role in understanding disease, from finding new diagnostic biomarkers to determining drug targets, and discovering new biopharmaceutical drugs.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.